Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A european multicenter trial

Gastroenterology

Volumn 116, Issue 5, 1999, Pages 1029-1034

  D'Haens, G ^a   Van Deventer, S ^a   Van Hogezand, R ^a   Chalmers, D ^a   Kothe, C ^a   Baert, F ^a   Braakman, T ^a   Schaible, T ^a   Geboes, K ^a   Rutgeerts, P ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; INFLIXIMAB; MONOCLONAL ANTIBODY; STEROID; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON CROHN DISEASE; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOSCOPIC BIOPSY; FEMALE; HISTOLOGY; HUMAN; INFLAMMATORY INFILTRATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0032913394     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70005-3     Document Type: Article

References (28)

1. R Modigliani JY Mary JF Simon A Cortot JC Soule R Gendre E Rene Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives Clinical, biological and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone Gastroenterology 98 1990 811 818
2. C Cellier T Sahmoud E Froguel A Adenis JF Belaiche JF Bretagne C Florent M Bouvry JY Mary R Modigliani Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives Correlations between clinical activity, endoscopic severity, and biological parameters in colonic and ileocolonic Crohn's disease. A multicenter prospective study of 121 cases Gut 35 1994 231 235
3. B Landi TN Anh A Cortot JC Soule E Rene JP Gendre P Bories A See JY Metman R Modigliani Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial Gastroenterology 102 1992 1647 1653
4. B Olaison R Sjodahl C Tagesson Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation Gut 31 1990 325 328
5. WJ Sandborn EC Van Os BJ Zins WJ Tremaine DC Mays JJ Lipsky An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease Gastroenterology 109 1995 1808 1817
6. G D'Haens K Geboes E Ponette E Penninckx P Rutgeerts Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease Gastroenterology 112 1997 1475 1481
7. RA Kozarek DJ Patterson MD Gelfand VA Botoman TJ Ball KR Wilske Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease Ann Intern Med 110 1989 353 356
8. HM Van Dullemen SJH Van Deventer DW Hommes HA Bijl J Jansen GN Tytgat J Woody Treatment of Crohn's disease with anti–tumor necrosis factor chimeric monoclonal antibody (cA2) Gastroenterology 109 1995 129 135
9. SR Targan SB Hanauer SJH van Deventer L Mayer DH Present T Braakman KL DeWoody TF Schaible P Rutgeerts A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease N Engl J Med 337 1997 1029 1035
10. JY Mary R Modigliani for the Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif GETAID Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study Gut 30 1989 983 989
11. GR D'Haens K Geboes M Peeters F Baert F Penninckx P Rutgeerts Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum Gastroenterology 114 1998 262 267
12. WR Best JM Bektel JW Singleton Rederived values of the eight coefficients of Crohn's disease activity index Gastroenterology 77 1979 843 846
13. MF Graham Stricture formation in Crohn's disease: wound healing in the intestine SR Targan F Shanahan Inflammatory bowel disease: from bench to bedside 1994 Williams & Wilkins Baltimore, MD 171 179
14. DP O'Donoghue AM Dawson J Powell-Tuck RL Bown JE Lennard-Jones Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease Lancet 2 1978 955 957
15. JL Rosenberg B Levin AJ Wall JB Kirsner A controlled trial of azathioprine in Crohn's disease Am J Dig Dis 20 1975 721 726
16. S Candy J Wright M Gerber G Adams M Gerig R Goodman A controlled double blind study of azathioprine in the management of Crohn's disease Gut 37 1995 674 678
17. JM Willoughby PJ Kumar J Beckett AM Dawson Controlled trial of azathioprine in Crohn's disease Lancet 2 1971 944 947
18. DH Present BI Korelitz N Wisch JL Glass BS Pasternack Treatment of Crohn's disease with 6-mercaptopurine. A long-term randomized double-blind study N Engl J Med 302 1980 981 987
19. TT MacDonald P Hutchings M-Y Choy S Murch A Cooke Tumornecrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine Clin Exp Immunol 81 1990 301 305
20. SH Murch SP Braegger JA Walker-Smith TT MacDonald Location of tumor necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease Gut 34 1993 1705 1709
21. RN Maini MJ Elliott FM Brennan M Feldmann Beneficial effects of tumor necrosis factor-α blockade in rheumatoid arthritis Clin Exp Immunol 101 1995 207 212
22. AP Cope M Londei NR Chu SB Cohen MJ Eliott FM Brennan RN Maini M Feldmann Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex: reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis J Clin Invest 94 1994 749 760
23. RA Kozarek DJ Patterson MD Gelfand VA Botoman TJ Ball KR Wilske Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease Ann Intern Med 110 1989 353 356
24. RM Beattie EJ Schiffrin A Donnet-Hughes AC Huggett P Domizio TT MacDonald JA Walker-Smith Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease Aliment Pharmacol Ther 8 1994 609 615
25. JME Fell A Hollis P Kitching M Paintin F Arnaud-Battandier TT MacDonald JA Walker-Smith Resolution of mucosal inflammation and fall in IL-1 beta mRNA in active Crohn's disease in response to polymeric diet CT3211 (abstr) J Pediatr Gastroenterol Nutr 24 1997 474
26. JA Walker-Smith Progress in understanding paediatric IBD problems GNJ Tytgat JFWM Bartelsman SJH van Deventer IBD, report of the Falk Symposium 85 1995 Kluwer Academic Dordrecht, Netherlands: 329 333
27. FJ Baert G D'Haens M Peeters MI Hiele TF Schaible D Shealy K Geboes PJ Rutgeerts Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis Gastroenterology 116 1999 22 28
28. P Rutgeerts G D'Haens SJH van Deventer DH Present L Mayer SB Hanauer TAJ Braakman KL De Woody TF Schaible SR Targan the Crohn's disease cA2 study group Retreatment with anti-TNF-α chimeric antibody (cA2) effectively maintains cA2-induced remission in Crohn's disease (abstr) Gastroenterology 112 1997 A1078